New Advances in Immunomodulation Using Biomaterials

A special issue of Cells (ISSN 2073-4409).

Deadline for manuscript submissions: 30 July 2026 | Viewed by 788

Special Issue Editors


E-Mail Website
Guest Editor
Independent Researcher, San Diego, CA, USA
Interests: cancer; cardiovascular diseases; immunomodulation; neuromodulation and regenerative medicine

Special Issue Information

Dear Colleagues,

Immunomodulatory biomaterials and devices have emerged as one of the most powerful frontiers in biomedical science. These biomaterials and devices enable control over immune responses and integrate principles of materials science, immunology, and engineering. The specific function of these platforms can be designed to present biological signals to recruit or reprogram immune cells and create microenvironments that direct tissue repair or enhance therapeutic efficacy. Over the last decade, the field has expanded rapidly from immune-instructive hydrogels and nanoparticle delivery systems to advanced scaffolds and engineered matrices that actively engage immune pathways.

However, fundamental challenges remain in understanding how material properties, such as mechanics, biocompatibility, degradability, surface chemistry, and ligand presentation, shape immune cell behavior and host responses. Deciphering these interactions is key to designing next-generation biomaterials that can achieve selective immunomodulation, minimize adverse reactions, and promote durable therapeutic outcomes.

For this Special Issue on New Advances in Immunomodulation Using Biomaterials, we invite original research articles and reviews that advance our understanding of how biomaterials can be used to modulate immune function across diverse applications such as solid tumor treatment, cardiovascular diseases, tissue repair and regeneration, infectious diseases, etc.

This Special Issue will highlight studies that reveal how biomaterials can be engineered to harness or modulate immunity, with the goal of advancing next-generation therapies that are safer and more effective.

We look forward to receiving your contributions to this exciting and rapidly evolving field.

Prof. Dr. Gundula Schulze-Tanzil
Dr. Vaishali Inamdar
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • immunomodulation
  • biomaterials
  • cell–material interactions
  • biocompatibility
  • immune system

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

19 pages, 3123 KB  
Article
Static Magnetic Field-Mediated Parathyroid Xenotransplantation Modulates Lymphocyte Migration: A Potential Immunosuppression-Free Long-Term Treatment for Hypoparathyroidism
by Ahmed Alperen Tuncer, Gülnihal Bozdağ, Ezgi Hacıhasanoğlu, Özge Karabıyık Acar, Fikrettin Şahin, Gamze Torun Köse and Erhan Ayşan
Cells 2026, 15(7), 600; https://doi.org/10.3390/cells15070600 - 28 Mar 2026
Viewed by 545
Abstract
Static magnetic fields (SMFs) are underexplored as biophysical tools for transplant immunomodulation. This study investigated a 300 mT SMF as a non-pharmacological adjuvant to enhance graft survival in parathyroid xenotransplantation. Human parathyroid tissues were transplanted into Sprague-Dawley rats (n = 20) across four [...] Read more.
Static magnetic fields (SMFs) are underexplored as biophysical tools for transplant immunomodulation. This study investigated a 300 mT SMF as a non-pharmacological adjuvant to enhance graft survival in parathyroid xenotransplantation. Human parathyroid tissues were transplanted into Sprague-Dawley rats (n = 20) across four groups: control (G1), SMF-only (G2), transplantation-only (G3), and SMF-assisted transplantation (G4). Following 30-day continuous SMF exposure, functional and immunological assessments were performed. G4 achieved the highest systemic PTH recovery (p = 0.009) without altering intrinsic secretory capacity. Systemic cytokine profiling revealed significant IFN-gamma suppression in G4 (p = 0.0024), suggesting downregulation of Th1-mediated rejection pathways. While G2 showed pro-inflammatory increases (TNF-alpha, GM-CSF), G4 maintained baseline levels, confirming biocompatibility. IHC confirmed that SMF exposure sequestered lymphocytes to the graft periphery, preventing the diffuse infiltration observed in G3. In conclusion, continuous SMF exposure modulates the immune microenvironment by altering lymphocyte migration and IFN-gamma signaling. This biophysical strategy provides localized immunoprotection, potentially offering a drug-free alternative to systemic immunosuppression in endocrine tissue transplantation. Full article
(This article belongs to the Special Issue New Advances in Immunomodulation Using Biomaterials)
Show Figures

Figure 1

Back to TopTop